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Abstract
Background: The nature and underlying mechanisms of the observed increased vulnerability to posttraumatic
stress disorder (PTSD) in women are unclear.
Methods: We investigated the genetic overlap of PTSD with anthropometric traits and reproductive behaviors and
functions in women. The analysis was conducted using female-specific summary statistics from large genome-wide
association studies (GWAS) and a cohort of 3577 European American women (966 PTSD cases and 2611 trauma-
exposed controls). We applied a high-resolution polygenic score approach and Mendelian randomization analysis to
investigate genetic correlations and causal relationships.
Results: We observed an inverse association of PTSD with genetically determined anthropometric traits related to body
shape, independent of body mass index (BMI). The top association was related to BMI-adjusted waist circumference
(WCadj; R = –0.079, P < 0.001, Q = 0.011). We estimated a relative decrease of 64.6% (95% confidence interval = 27.5–82.7)
in the risk of PTSD per 1-SD increase in WCadj. MR-Egger regression intercept analysis showed no evidence of pleiotropic
effects in this association (Ppleiotropy = 0.979). We also observed associations of genetically determined WCadj with age at
first sexual intercourse and number of sexual partners (P = 0.013 and P < 0.001, respectively).
Conclusions: There is a putative causal relationship between genetically determined female body shape and PTSD,
which could be mediated by evolutionary mechanisms involved in human sexual behaviors.
Keywords: Trauma, Genetics, Women, Anthropometric traits
Background
Posttraumatic stress disorder (PTSD) is a mental illness
that affects susceptible individuals who have experi-
enced, witnessed, or been confronted with an event
involving actual or threatened dangers [1]. Individuals
affected by PTSD present symptoms that, according to
the DSM-5, include four diagnostic clusters (re-
experiencing, avoidance, negative cognitions and mood,
and arousal) [2]. At least one in nine American women
meet lifetime diagnostic criteria for PTSD and women’s
risk of PTSD is twice that of men [3]. Among women,
PTSD is also more likely to be chronic and associated
with greater functional impairment and distinct neuro-
biological profiles [4, 5]. Evidence suggests that women
are more vulnerable than men to develop PTSD when
exposed to similar traumas [6].
Women’s higher risk for PTSD likely arises from bio-
logic and social/environmental factors. For example, sex
differences in trauma exposure may partially explain the
differential risk for PTSD. Women are more likely to be
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exposed to sexual violence, which has a high conditional
risk of PTSD [7]. Alternatively, the pattern of results
from twin studies suggests that PTSD may be more her-
itable in women than in men [8, 9] and results from a
recent genome-wide investigation also demonstrate
higher molecular heritability in women [10]. Sex hor-
mones, particularly estradiol and progesterone, have
been implicated as mediators of this risk, suggesting that
their effects on biological, behavioral, and cognitive
pathways augment the vulnerability to PTSD [11]. A re-
cent epigenome-wide association study supported this
possible mechanism; it reported an estrogen-dependent
association of HDAC4 with fear in female mice and
women with PTSD [12].
Genetic data can be used to investigate this complex
network of multiple factors. Polygenic risk score (PRS)
analyses and Mendelian randomization (MR) studies are
less biased by confounders than observational studies
and can be used to investigate the predisposition to
complex traits, identifying shared molecular pathways,
pleiotropy, and causal relationships [13, 14]. Here, we
used summary statistics from female-specific genome-
wide association studies (GWAS) of traits that may be
related to disease pathogenesis—i.e. anthropometric
characteristics [15], reproductive physiology and behav-
iors [16], and educational attainment [17]—to examine
the mechanisms underlying women’s vulnerability to
PTSD. Although these traits were previously indicated
as related to PTSD in women, testing a wide range of
genetic correlations can provide useful etiological in-
sights and help prioritize likely causal relationships [18].
A greater understanding of the biological and external
social processes involved in PTSD will help to address
the critically important interplay between two important
public health issues: PTSD and women’s health.
Methods
Cohorts from the Psychiatric Genomics Consortium PTSD
Workgroup
The individual data from the subjects included were
made available by the members of the Psychiatric Gen-
omics Consortium PTSD Workgroup. Details regarding
participants, genotyping, quality control, imputation,
and ancestry assignment were reported previously [10].
In the present study, we used data regarding female par-
ticipants from seven cohorts: Collaborative Genetic
Study of Nicotine Dependence [19]; Family Study of Co-
caine Dependence [20]; Yale-Penn [21]; Grady Trauma
Project [22]; Marine Resilience Study [23]; Nurses’
Health Study [24]; and Ohio National Guard [25]. Be-
cause the individuals in the GWAS that were used as
sources for summary statistics for the traits of interest
were of European descent, we restricted our analysis to
women of that population. Quality control criteria for
ancestry assignment and sex check are reported in our
previous publication [10]. We considered imputed geno-
types to maximize a consistent SNP (Single Nucleotide
Polymorphism) panel between the training and testing
sets. Imputed SNPs with high imputation quality (geno-
type call probability ≥ 0.8), minor allele frequency ≥ 1%,
missingness per marker ≤ 5%, missingness per individ-
ual ≤ 5%, and Hardy-Weinberg equilibrium P > 10–4 were
retained. After applying these quality control criteria, we
retained information on 4,875,110 variants in a final
sample of 3577 women (966 PTSD cases and 2611
trauma-exposed controls). To investigate the specificity
of our findings for PTSD in women, we investigated a
sample of 4628 men (501 PTSD cases and 4127 trauma-
exposed controls) from the same cohorts of the Psychi-
atric Genomics Consortium PTSD Workgroup. The
same quality control criteria were applied to the data
from men. Principal component analysis of the final
sample was conducted using PLINK 1.9 [26] after link-
age disequilibrium (LD) pruning (R2 < 0.2).
Polygenic risk score analysis
We conducted cross-phenotype PRS analyses using
PRSice software [27] (available at http://prsice.info/). This
method permits testing whether the polygenic compo-
nents of inheritance have a substantial effect on multiple
complex traits [28]. For polygenic profile scoring, we used
summary statistics generated from female-specific GWAS
of 17 traits (Table 1) conducted by the Genetic Investiga-
tion of ANthropometric Traits (GIANT) Consortium
[29–32], the Reproductive Genetics (Reprogen) Consor-
tium [33, 34], and the Social Science Genetic Association
Consortium (SSGAC) [35, 36]. None of the PGC-PTSD
cohorts was included in these previous GWAS and,
thereby, no large overlap is expected among these sam-
ples. We considered multiple association P value thresh-
olds (PT = 10–8, 10–7, 10–6, 10–5, 10–4, 0.001, 0.05, 0.3, 0.5)
for SNP inclusion, i.e. we conducted a high-resolution
analysis. The PRS were calculated after using P value-
informed clumping with a LD cut-off of R2 = 0.3 within a
500-kb window, and excluding the Major Histocompati-
bility Complex region of the genome because of its com-
plex LD structure. The PRS that were generated were
fitted in regression models with adjustments for the top
ten ancestry principal components to calculate Nagelk-
erke’s R as the figure of merit for prediction ability. We
applied false discovery rate (FDR) multiple testing correc-
tion (Q < 0.05) to correct for the number of PRS and
thresholds tested (a total of 170 tests). A gene ontology
(GO) enrichment analysis was conducted based on the
PRS results: the variants included in the significant PRS
with direction concordant with PRS direction were con-
sidered in the enrichment analysis. Variants were mapped
to the nearest genes and then the gene loci were entered
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into the enrichment analysis conducted using the PAN-
THER v11.1 Overrepresentation Test (release 20160715;
Reference List: Homo Sapiens) [37]. FDR correction was
applied to the enrichment results to account for multiple
testing. The GO enrichment results were further investi-
gated using REVIGO [38]. Specifically, GO enrichments
were used to make a graph-based visualization considering
an allowed similarity of 0.7, UniProt as reference database,
and SimRel method as the semantic similarity measure.
Two-sample Mendelian randomization analysis
The two-sample MR analysis was conducted using the R
package MendelianRandomization (available at https://
cran.r-project.org/web/packages/MendelianRandomization
/index.html) and the GWAS summary statistics. This is a
strategy to test cause–effect associations, in which evi-
dence on the associations of genetic variants (i.e. instru-
mental variable) with the risk factor (i.e. exposure) and
with the outcome comes from two sources [39]. We used
SNPs associated with waist circumference adjusted for
body mass index (BMI) (WCadj P < 10
-8 N = 31), which
showed the most significant correlation with PTSD in our
PRS analysis (FDR Q = 0.011), as the instrumental variable.
The SNP-exposure and SNP-outcome coefficients (WCadj
and PTSD associations, respectively) were combined using
an inverse-variance-weighted approach to give an overall
estimate of the causal effect. To verify the stability of the
results, we compared the findings obtained from inverse-
variance-weighted analysis to the results of other MR ap-
proaches, including simple median, weighted median, and
MR-Egger regression. Different methods have sensitivities
to different potential issues, accommodate different sce-
narios, and vary in their statistical efficiency. Comparing
the results of different methods permits validation of the
analyses. MR-Egger regression intercept was considered to
test for the presence of pleiotropic effects of the SNPs on
the outcome [40]. Due to the lack of genome-wide signifi-
cant loci for PTSD, it was not possible to apply reverse
MR to test the effect of PTSD-associated alleles on WCadj
to confirm the direction of the causal relationship between
these traits [41]. However, we used a reverse PRS analysis
of PTSD to predict WCadj and other anthropometric traits
based on GWAS summary statistics. This reverse PRS
analysis was conducted using PRSice software [27]. To
Table 1 GWAS summary statistics used for polygenic risk scoring
Consortium Trait Abbreviation Women N Variant N Data link
Genetic Investigation of
ANthropometric Traits (GIANT)
Body mass index BMI 128,698 2,494,584 http://portals.broadinstitute.org/collaboration/giant/
index.php/GIANT_consortium_data_files
BMI (age≤
50 years)
BMI<50 52,270 2,407,668
BMI (age≥
50 years)
BMI>50 86,731 2,407,629
Height Height 64,811 2,748,519
Hip circumference HIP 85,973 2,466,814
HIP adjusted for
BMI
HIPadj 84,787 2,466,814
Waist
circumference
WC 90,543 2,444,344
WC adjusted for
BMI
WCadj 89,759 2,473,027
Waist–hip ratio WHR 85,466 2,466,093
WHR adjusted for
BMI
WHRadj 84,222 2,467,768
WHRadj (age≤
50 years)
WHRadj<50 34,523 2,366,527
WHRadj (age≥
50 years)
WHRadj>50 56,150 2,366,567
Reproductive Genetics
(Reprogen)
Age at menarche Menarche 182,416 2,441,881 http://www.reprogen.org/data_download.html
Age at
menopause
Menopause 69,360 2,418,695
Social Science Genetic
Association Consortium (SSGAC)
Age at first birth AFB 158,856 2,470,136 http://www.thessgac.org/data
Education years EDU 122,427 7,643,300
Number of
children ever born
NEB 222,837 2,471,862
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follow up a possible “evolutionary link” between female
body shape and PTSD, we tested the association of genet-
ically determined WCadj with age at first sexual intercourse
(AFS) and number of sexual partners (NSP). For AFS, we
used female-specific summary statistics from a recent
GWAS, including women of European descent only [42].
This previous GWAS was conducted considering a range
of AFS, which also includes a small fraction of individuals
who had their first sexual intercourse before 12 years of
age. For NSP, we used UK Biobank data on a total of
58,356 unrelated women of European descent. We calcu-
lated the association of the top 31 SNPs associated with
WCadj (P < 10
–8) with NSP using a linear regression model.
Before being entered into the analysis, NSP was adjusted
for age and the top ten ancestry principal components and
then normalized using appropriate Box–Cox power
transformations.
Data availability
Data supporting the findings of this study are available
within the article and its Additional files. GWAS Sum-
mary level data used to calculate PRS in this study were
obtained from links reported in Table 1.
Results
We used summary statistics generated from female-
specific GWAS of 17 traits (Table 1) to yield polygenic
profile scoring and tested the association of the derived
PRS with PTSD considering multiple PT and using sam-
ples from the Psychiatric Genomics Consortium PTSD
Workgroup (966 PTSD cases and 2611 trauma-exposed
controls). Six PRS showed correlations with PTSD that
survived FDR multiple testing correction (Q < 0.05;
Table 2; Additional file 1). Although LD score regression
is designed to analyze large sample sizes [18], using this
method we nevertheless replicated the directions of five
correlations and two of them survived multiple testing
correction (Additional file 2). The strongest PRS result
was observed for WCadj: women with high genetically pre-
dicted WCadj have low PTSD risk (PT: 10
–8; R = –0.079, P
< 0.001, Q = 0.011). Additional file 3 shows the distribu-
tion of WCadj PRS in PTSD cases and controls. The same
variants included in the WCadj PRS also drove four of the
other associations observed: waist–hip ratio (WHR, PT =
10–7; R = –0.064, P = 0.001, Q = 0.023); WHR adjusted for
BMI (WHRadj, PT = 10
–7; R = –0.059, P = 0.001, Q =
0.030), WHRadj in women aged < 50 years (WHRadj<50,
PT = 10–6; R = –0.076, P = 1.25*10–4, Q = 0.011), and
WHRadj in women aged > 50 years (WHRadj>50, PT = 10
–8;
R = –0.065, P = 0.001, Q = 0.023). Additional file 4 reports
the strong correlations of WCadj PRS with these other an-
thropometric traits. The association between WCadj PRS
and PTSD appears to be specific to women; no correlation
was observed in men (Additional file 5).
Among the significant PRS, the finding related to Age at
First Birth (AFB) PRS is the only one that appears to be
independent from the WCadj signal because its top correl-
ation is due to the cumulative effects of a large number of
variants (AFB top-PT = 0.3, SNP N = 64,579) and not to
the effect of a small number of strongly associated loci
(WCadj top-PT = 10
–8, N = 31). We observed that women
with a high genetically predicted AFB have low PTSD risk
(R = –0.064, P = 0.001, Q = 0.023). Additional file 6 shows
the distribution of AFB PRS in PTSD cases and controls.
No association between AFB PRS and PTSD was observed
in men (Additional file 7). Since this genetic overlap ap-
pear to be related to the additive effect of a large number
of variants (N = 64,579), we investigated which molecular
mechanisms are shared between PTSD and AFB. The GO
enrichment analysis based on AFB results highlighted sev-
eral potential molecular mechanisms involved (Q < 0.05;
Additional file 8, respectively). Because we observed a
large number of significant GO enrichments (Q < 0.05) re-
lated to the AFB–PTSD result (N = 40), we conducted a
similarity-based network analysis among the significant
GO enrichments. This analysis highlighted a GO cluster
(Additional file 9) related to multiple signaling mecha-
nisms (e.g. calcium-mediated signaling and MAPK
cascade).
To investigate further the WCadj-PTSD genetic correl-
ation, we applied a MR approach to assess the causative
mechanisms of this association. We used an inverse-
variance-weighted method to calculate an overall esti-
mate of the causal effect considering the coefficients re-
lated to the association of these variants with PTSD and
Table 2 Top genetic correlations between PTSD and PRS tested
PRS PT SNP N R P value Q value
WCadj 10
–8 31 –0.079 6.77 × 10–5 0.011
WHRadj<50 10
–6 19 –0.076 1.25 × 10–4 0.011
WHRadj>50 10
–8 19 –0.065 0.001 0.023
AFB 0.3 64,579 –0.064 0.001 0.023
WHR 10–7 32 –0.064 0.001 0.023
WHRadj 10
–7 51 –0.059 0.003 0.030
Menarche 10–3 1510 0.049 0.013 0.074
BMI<50 10
–7 26 0.048 0.015 0.077
HIP 10–5 94 0.045 0.024 0.108
Height 0.1 25,369 0.042 0.035 0.144
WC 10–8 20 0.034 0.082 0.266
BMI>50 10
–5 104 0.033 0.099 0.306
BMI 10–4 316 0.032 0.103 0.312
NEB 10–6 2 –0.029 0.141 0.386
HIPadj 0.05 13,338 0.029 0.147 0.390
EDU 10–8 17 –0.021 0.294 0.641
Menopause 10–5 163 0.018 0.360 0.686
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WCadj (Fig. 1; Additional file 10). This analysis showed a
significant association of effect sizes of WCadj-associated
SNPs with effect sizes estimated in our PTSD sample
(OR = 0.35; 95% confidence interval [CI] = 0.17–0.73; P
= 0.008). This translated to a relative decrease of 64.6%
(95% CI = 27.5–82.7) in the risk of PTSD per 1-SD in-
crease in WCadj. This result was consistent considering
multiple MR approaches (Additional file 11). Further-
more, the consistency between PRS and MR analyses
confirms that there is no sample overlap that is biasing
our results. Indeed, these two approaches are susceptible
to biases from sample overlaps, but the bias would be in
opposite directions: risk of false-positive results in PRS
and risk of false-negative results in two-sample MR [43].
Considering the MR-Egger regression intercept, we also
observe that the markers did not show evidence of pleio-
tropic effects (Ppleiotropy = 0.979), suggesting that the as-
sociation of these variants with PTSD is mediated by
their effect on body shape. To investigate further the po-
tential causal relationship between PTSD and female
body shape, we tested whether the PTSD PRS correlated
with WCadj. A causal relationship between two traits
should show asymmetry in the effect sizes of associated
variants [41]. We observed asymmetry between PTSD
and WCadj: PTSD-associated variants showed no effect
on WCadj (P > 0.10; Additional file 12) but strongly
predicted BMI (P = 5.68*10–7) and other BMI-related an-
thropometric traits (Additional file 13). These results
support a causal relationship between WCadj and PTSD.
We tested whether genetically determined female body
shape correlated with sexual behaviors in women using
female-specific genetic information regarding AFS and
NSP (Additional file 10). Considering a penalized robust
MR-Egger regression, we observed associations of WCadj
with AFS (Beta = –0.25, SE = 0.10, P = 0.013; Fig. 2) and
NSP (Beta = 0.16, SE = 0.04, P < 0.001; Fig. 2) with sig-
nificant evidence of pleiotropy in both results (Ppleiotropy
= 0.017 and < 0.001, respectively), suggesting that the ef-
fects of these variants on sexual behaviors could be due
to multiple mechanisms.
Discussion
We found associations of the genetic risk for PTSD in
women with genetically determined female body shape
and reproductive behaviors. These findings provide
novel insight into the mechanisms that may underlie the
genetic vulnerability to PTSD in women.
Our strongest result reflects an inverse relationship be-
tween genetically determined female body shape and the
genetic risk for PTSD. We observed that SNPs associated
with anthropometric traits related to body shape independ-
ently from BMI (i.e. WCadj, WHR, WHRadj, WHRadj<50,
Fig. 1 SNP-exposure (WCadj associations) and SNP-outcome (PTSD associations) coefficients used in the MR analysis. Error bars (95% CIs) are
reported for each association. The solid line represents the inverse-variance-weighted estimate
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WHRadj>50) are linked to the risk for PTSD. No analogous
association was present in our male cohort. Human body
shape is the result of strong evolutionary pressures, includ-
ing sexual selection, with evident differences in selection be-
tween women and men [44]. The dissimilarities between
sexes are largely due to adaptation mechanisms related to
female reproductive function [44]. To facilitate childbirth,
the pelvis is proportionately larger in women than in men.
There is also variability in fat accumulation and distribution
that are related to women’s need for energy to be used dur-
ing pregnancy and nursing: women have a higher percent-
age of body fat; men accumulate fat in the abdominal
region, while women accumulate fat in hips, buttocks,
thighs, and the lower abdomen [45]. Consistent with the
presence of different regulatory mechanisms related to hu-
man body shape, GWAS from the GIANT consortium
identified several loci with sex-specific effects and most of
them have larger effects in women than in men [30, 32]. Al-
though these sex differences and their regulatory mecha-
nisms are well-known, to our knowledge no large study has
investigated the role of genetically determined body shape
in women’s mental health. In our study, we observed that a
genetically determined evolution-related body shape (i.e.
low WCadj, WHR, and WHRadj) was associated with in-
creased risk of PTSD. A small study reported an association
between observational (i.e. phenotypically observed) WHR
and PTSD concordant with our finding [46]. Our data are
most consistent with a causal relationship between WCadj
and PTSD in women. Considering MR-Egger regression
intercept, we did not observe a pleiotropic effect between
WCadj and PTSD. Conversely, there was an asymmetry in
the effect sizes of associated variants: WCadj-associated vari-
ants affect the risk of PTSD, but PTSD-associated variants
do not affect female body shape. Previous evolutionary stud-
ies reported that body shape in women is one of the traits
related to reproductive attractiveness that has been selected
during human evolution [47]. We note that female repro-
ductive attractiveness, which is determined by evolutionary
selection pressures, is distinct from socio-cultural norms
about female attractiveness that are known to differ over
time and place [48]. Our data can be interpreted as sup-
porting that specific anthropometric characteristics may be
related to PTSD via their role in increasing the risk of trau-
matic experiences related to undesired sexual behavior.
Further evidence of an apparent causal relationship be-
tween WCadj and experiences related to sexual function is
provided by the analysis of AFS and NSP. Genetically de-
termined WCadj is associated with AFS and NSP; this pro-
vides additional evidence of the relationship between the
female body shape and behaviors related to sexual interac-
tions. As indicated by the significant evidence of pleiotropy,
the relationship between female body shape and sexual be-
havior is likely mediated by multiple factors, including be-
havioral mechanisms and physiological processes related to
reproductive function. Unfortunately, we cannot investi-
gate further the relationship between female body shape
and traumatic specific experiences, such as sexual assault,
because trauma type information is not currently available
in the PGC PTSD dataset. We hope to be able to do it in
the future. In particular, we believe that longitudinal stud-
ies that include detailed life course assessments of trau-
matic experience will be needed to better understand the
role of female body shape in risk of sexual assault or other
traumatic event exposure.
Our investigation also identified an association be-
tween AFB and PTSD: genetically predicted young ma-
ternal AFB is associated with an increase of PTSD risk.
This is consistent with epidemiologic observations of an
inverse association between maternal AFB and psychi-
atric distress: mothers giving birth in their teens have an
increased risk of a lifetime behavior disorder, PTSD, or
an anxiety disorder compared to women who were older
Fig. 2 SNP-exposure (WCadj associations) and SNP-outcome (AFS associations, left; NSP associations, right) coefficients used in the MR analysis.
Error bars (95% CIs) are reported for each association. The solid line represents the MR-Egger estimate
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at first birth [49]. The AFB–PTSD correlation is due to
a genome-wide genetic overlap that includes thousands
of independent variants, which is different from the body
shape result, which was influenced by a small number of
variants. This could indicate that these two traits share
some pathways involved in their predisposition. Our en-
richment analysis identified several molecular processes.
Among them, we observed a large GO cluster of signal-
ing mechanisms that includes several that are known to
be involved in the response to traumatic experience,
such as calcium-mediated signaling and the MAPK cas-
cade [50, 51]. Observational studies have reported that
early trauma exposures are associated with an increased
risk of teen pregnancy. In particular, childhood sexual
abuse is associated with increased risk for subsequent
adolescent pregnancy [52, 53]. In line with this scenario,
we note that the AFB GWAS [35] was conducted with-
out excluding birth events from non-consensual sex. For
instance, although it accounts for a small fraction of the
sample investigated, some of the cohorts included in this
previous analysis also included births during childhood.
Accordingly, a possible explanation of the AFB–PTSD
correlation is that childhood abuse and sexual
victimization can contribute to AFB and PTSD, and
some of the trauma-response mechanisms involved may
be shared among these traits. These mechanisms appear
to be different from those related to the WCadj results.
The relationship between AFB and PTSD seems to be
due to a large genetic overlap (i.e. pleiotropy); WCadj ap-
pears to be involved in a causal mechanism related to
women’s vulnerability to PTSD (i.e. no pleiotropy).
Conclusions
In summary, using a genetic approach, we found two as-
sociations with the risk of PTSD in women related to
body shape and reproductive behaviors. Both mecha-
nisms appear to be female-specific (i.e. there was no
such association in men) and they suggest that sex dif-
ferences in trauma type prevalence and molecular mech-
anisms of trauma response contribute to the greater
vulnerability to PTSD observed in women. Our study
demonstrates how genetic research can successfully con-
tribute to the dissection of biological and non-biological
mechanisms relevant to women’s health.
Additional files
Additional file 1: Genetic correlations between PTSD and PRS tested in
women. (DOCX 19 kb)
Additional file 2: PTSD genetic correlations tested with LD score
regression analysis. (DOCX 12 kb)
Additional file 3: Distribution of WCadj PRS in PTSD cases and controls.
(DOCX 333 kb)
Additional file 4: Genetic correlation of WCadj PRS (SNP N = 31, PT =10–8)
with the other anthropometric traits associated with PTSD in women.
(DOCX 12 kb)
Additional file 5: Correlation between WCadj PRS and PTSD in men.
(DOCX 12 kb)
Additional file 6: Distribution of AFB PRS in PTSD cases and controls.
(DOCX 361 kb)
Additional file 7: Correlation between AFB PRS and PTSD in men.
(DOCX 12 kb)
Additional file 8: Gene Ontology (GO) enrichments (Q value < 0.05) for
variants with AFB GWAS P < 0.3 and effect direction concordant with the
AFB-PTSD correlation. (DOCX 14 kb)
Additional file 9: Similarity network based on GO enrichment results
related to the AFB-PTSD correlation. Bubble color indicates the GO P
value; bubble size indicates the frequency of the GO term in the Gene
Ontology Annotation (UniProt-GOA) Database which annotates all Uni-
Prot entries with GO terms. Highly similar GO terms are linked by edges
in the graph, where the line width indicates the degree of similarity.
(DOCX 179 kb)
Additional file 10: SNP-exposure and SNP-outcome coefficients of the
variants in included in the WCadj PRS. (DOCX 15 kb)
Additional file 11: SNP-exposure (WCadj associations) and SNP-
outcome (PTSD associations) coefficients used in the MR analysis. The
lines (see legend) represents the results observed considering different
methods. (DOCX 383 kb)
Additional file 12: Correlation between PTSD PRS and WCadj. (DOCX 12 kb)
Additional file 13: Top results of the reverse PRS analysis of PTSD with
respect to the main anthropometric traits. (DOCX 12 kb)
Abbreviations
AFB: Age at first birth; AFS: Age at first sexual intercourse; BMI: Body mass
index; FDR: False discovery rate; GO: Gene Ontology; GWAS: Genome-wide
association study; MR: Mendelian randomization; NSP: Number of sexual
partners; PRS: Polygenic risk score; PTSD: Posttraumatic stress disorder;
SNP: single nucleotide polymorphism; WCadj: BMI-adjusted waist
circumference; WHR: Waist–hip ratio; WHRadj: WHR adjusted for BMI;
WHRadj<50: WHRadj in women aged < 50 years; WHRadj>50: WHRadj in women
aged > 50 years
Acknowledgements
We thank study participants and research groups contributing to PGC-PTSD for
sharing their data. Part of this research has been conducted using the UK Biobank
Resource (application reference no. 19664). We acknowledge Naomi Wray of The
University of Queensland (Brisbane, Australia) for insightful comments about the
manuscript. We thank the members of the cited consortia of genome-wide asso-
ciation studies for making their data available. The members of the Psychiatric
Genomics Consortium Posttraumatic Stress Disorder Workgroup are: Laramie E
Duncan (Department of Psychiatry, Stanford University, Stanford, CA, USA, Broad
Institute of MIT and Harvard, Stanley Center for Psychiatric Research, Boston, MA,
USA, The Analytic and Translational Genetics Unit, Massachusetts General Hospital,
Boston, MA, USA), Andrew Ratanatharathorn (Department of Epidemiology,
Columbia University, New York, NY, USA), Allison E Aiello (Department of
Epidemiology, Gillings School of Global Public Health, University of North Carolina,
Chapel Hill, Chapel Hill, NC, USA), Lynn M Almli (Department of Psychiatry and
Behavioral Sciences, Emory University, Atlanta, GA, USA), Ananda B Amstadter
(Department of Psychiatry, Virginia Commonwealth University, Richmond, VA,
USA), Allison E Ashley-Koch (Department of Medicine, Duke Molecular Physiology
Institute, Duke University Medical Center, Durham, NC, USA), Dewleen G Baker
(Veterans Affairs San Diego Healthcare System and Veterans Affairs Center of
Excellence for Stress and Mental Health, San Diego, CA, USA, Department of
Psychiatry, University of California, San Diego, San Diego, CA, USA), Jean C
Beckham (Veterans Affairs Durham Healthcare System, Durham, NC, USA,
Department of Psychiatry and Behavioral Sciences, Duke University Medical
Center, Durham, NC, USA), Laura J Bierut (Department of Psychiatry, Washington
University School of Medicine, St Louis, MO, USA), Jonathan Bisson (Division of
Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK),
Bekh Bradley (Atlanta VA Medical Center, Atlanta, GA, USA, Department of
Polimanti et al. Genome Medicine  (2017) 9:99 Page 7 of 10
Psychiatry, Emory University, Atlanta, GA, USA), "Chia-Yen Chen" (The Analytic and
Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA,
Psychiatric and Neurodevelopmental Genetics Unit, Center for Human, enetic
Research, and Department of Psychiatry, Massachusetts General Hospital, Boston,
MA, USA, Department of Psychiatry, Harvard University, Cambridge, MA, USA),
Shareefa Dalvie (Division of Human Genetics, University of Cape Town, Cape
Town, South Africa), Lindsay A Farrer (Biomedical Genetics, Boston University
School of Medicine, Boston, MA, USA), Sandro Galea (Boston University School of
Public Health, Boston, MA, USA), Melanie E Garrett (Department of Medicine, Duke
Molecular Physiology Institute, Duke University Medical Center, Durham, NC, USA),
Joel E Gelernter (Department of Psychiatry, Yale University School of Medicine
and VA CT Healthcare System, New Haven, CT, USA), Guia Guffanti (Department
of Psychiatry, Harvard University, Cambridge, MA, USA, Department of Psychiatry,
McLean Hospital, Belmont, MA, USA), Michael A Hauser (Department of Medicine,
Duke Molecular Physiology Institute, Duke University Medical Center, Durham, NC,
USA), Eric O Johnson (RTI International, Research Triangle Park, NC, USA), Ronald C
Kessler (Department of Health Care Policy, Harvard Medical School, Boston, MA,
USA), Nathan A Kimbrel (Veterans Affairs Durham Healthcare System, Durham, NC,
USA, Department of Psychiatry and Behavioral Sciences, Duke University Medical
Center, Durham, NC, USA), Anthony King (Department of Psychiatry, University of
Michigan, Ann Arbor, MI, USA), Nastassja Koen (Department of Psychiatry and
Mental Health, University of Cape Town, Cape Town, South Africa, MRC Unit on
Anxiety & Stress Disorders, Groote Schuur Hospital, Cape Town, South Africa),
Henry R Kranzler (Department of Psychiatry, University of Pennsylvania Perelman
School of Medicine and VISN 4 MIRECC, Crescenz VAMC, Philadelphia, PA, USA),
Mark W Logue (VA Boston Healthcare System, Jamaica Plain, MA, USA, Department
of Medicine, Boston University School of Medicine, Boston, MA, USA), Adam X
Maihofer (Department of Psychiatry, University of California, San Diego, La Jolla,
CA, USA), Alicia R Martin (Broad Institute of MIT and Harvard, Stanley Center for
Psychiatric Research, Boston, MA, USA, The Analytic and Translational Genetics Unit,
Massachusetts General Hospital, Boston, MA, USA), Mark W Miller (VA Boston
Healthcare System, Jamaica Plain, MA, USA, Department of Psychiatry, Boston
University School of Medicine, Boston, MA, USA), Rajendra A Morey (Department of
Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC,
USA, Durham VA Medical Center, Durham, NC, USA), Nicole R Nugent (Division of
Behavioral Genetics, Department of Psychiatry, Rhode Island Hospital, Providence, RI,
USA, Department of Psychiatry and Human Behavior, Alpert Medical School of
Brown University, Providence, RI, USA), John P Rice (Department of Psychiatry,
Washington University, St Louis, MO, USA), Stephan Ripke (Broad Institute of MIT
and Harvard, Stanley Center for Psychiatric Research, Boston, MA, USA, The Analytic
and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA,
Department of Psychiatry and Psychotherapy, Charité, Campus Mitte, Berlin,
Germany), Andrea L Roberts (Department of Social and Behavioral Sciences,
Harvard T. H. Chan School of Public Health Cambridge, MA, USA), Nancy L Saccone
(Department of Genetics, Washington University, St Louis, MO, USA), Jordan W
Smoller (Broad Institute of MIT and Harvard, Stanley Center for Psychiatric Research,
Boston, MA, USA, Psychiatric and Neurodevelopmental Genetics Unit, Center for
Human Genetic, Research, and Department of Psychiatry, Massachusetts General
Hospital, Boston, MA, USA), Daniel J Stein (Department of Psychiatry and Mental
Health, University of Cape Town, Cape Town, South Africa, MRC Unit on Anxiety &
Stress Disorders, Groote Schuur Hospital, Cape Town, South Africa), Murray B Stein
(Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA,
Veterans Affairs San Diego Healthcare System, San Diego, CA, USA, Department
of Family Medicine and Public Health, University of California, San Diego, La
Jolla, CA, USA), Jennifer A Sumner (Center for Cardiovascular Behavioral Health,
Columbia University Medical Center, New York, NY, USA), Monica Uddin
(Department of Psychology and Carl R. Woese Institute for Genomic Biology,
University of Illinois at Urbana-Champaign, Urbana, IL, USA), Robert J Ursano
(Center for the Study of Traumatic Stress, Department of Psychiatry, Uniformed
Services University of the Health Sciences, Bethesda, MD, USA), Derek E Wildman
(Department of Molecular & Integrative Physiology and Carl R. Woese Institute for
Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA),
Rachel Yehuda (James J. Peters Bronx Veterans Affairs and Department of
Psychiatry, Icahn School of Medicine at Mount Sinai, Bronx, NY, USA, Department
of Neuroscience, Icahn School of Medicine at Mount Sinai, Bronx, NY, USA), Hongyu
Zhao (Department of Biostatistics, Yale University, New Haven, CT, USA), Mark J Daly
(Broad Institute of MIT and Harvard, Stanley Center for Psychiatric Research, Boston,
MA, USA, The Analytic and Translational Genetics Unit, Massachusetts General
Hospital, Boston, MA, USA), Israel Liberzon (Department of Psychiatry, University of
Michigan, Ann Arbor, MI, USA, VA Ann Arbor Health System, Ann Arbor, MI, USA),
Kerry J Ressler (Department of Psychiatry, Harvard University, Cambridge, MA, USA,
Department of Psychiatry, McLean Hospital, Belmont, MA, USA), Caroline M
Nievergelt (Veterans Affairs San Diego Healthcare System and Veterans Affairs
Center of Excellence for Stress and Mental Health, San Diego, CA, USA, Depart-
ment of Psychiatry, University of California, San Diego, San Diego, CA, USA),
Karestan C Koenen (Broad Institute of MIT and Harvard, Stanley Center for
Psychiatric Research, Boston, MA, USA, Psychiatric and Neurodevelopmental
Genetics Unit, Center for Human Genetic Research, and Department of Psychiatry,
Massachusetts General Hospital, Boston, MA, USA, Department of Epidemiology,
Harvard T. H. Chan School of Public Health, Cambridge, MA, USA).
Funding
This study was supported by National Institutes of Health grants R01
MH106595 and U01 MH109532, and the VA National Center for PTSD
Research.
Availability of data and materials
All data generated during this study are included in this published article
and its Additional files.
Authors’ contributions
RP, MBS, and JG were involved in study design. ABA, LMA, DGB, LJB, BB, LAF,
EOJ, AK, HRK, AXM, JPR, ALR, NLS, HZ, IL, KJR, CMN, KCK, and JG were
involved in cohort ascertainment, phenotypic characterization, genotyping,
and/or recruitment. RP carried out statistical analysis. RP wrote the first draft
of the manuscript and all authors contributed to the final version of the
manuscript. All authors read and approved the final manuscript.
Ethics approval and consent to participate
This study is based on the PGC-PTSD data freeze 1, which is an anonymized
dataset. The cohorts contributing to the PGC-PTSD workgroup included in the
present analysis are: Collaborative Genetic Study of Nicotine Dependence;
Family Study of Cocaine Dependence; Yale-Penn; Grady Trauma Project; Marine
Resilience Study; Nurses’ Health Study; and Ohio National Guard. Each of the
contributing studies has an institutional review board-approved protocol to
investigate the genetics of PTSD and provided the data consistent with their
approved protocols. All studies involved in the PGC-PTSD workgroup comply
with the Declaration of Helsinki. Additionally, we used GWAS summary statistics
from the GIANT, Reprogen, and SSGAC consortia, which shared this information
in accordance with the protocols approved for the cohorts participating in
these studies.
Consent for publication
Not applicable.
Competing interests
Dr. Stein has in the last three years been a consultant for Actelion
Pharmaceuticals, Healthcare Management Technologies, Janssen, Pfizer,
Resilience Therapeutics, Tonix Pharmaceuticals, and Oxeia
Biopharmaceuticals. Dr. Kranzler has been an advisory board member,
consultant, or CME speaker for Indivior and Lundbeck. He is also a member
of the American Society of Clinical Psychopharmacology’s Alcohol Clinical
Trials Initiative, which was supported in the last three years by AbbVie,
Alkermes, Ethypharm, Indivior, Lilly, Lundbeck, Pfizer, Arbor, and Amygdala
Neurosciences. Dr. Bierut is listed as an inventor on Issued US Patent
8,080,371, “Markers for Addiction” covering the use of certain SNPs in
determining the diagnosis, prognosis, and treatment of addiction. Dr
Liberzon has been a consultant for ARMGO Pharmaceutical, Sunovion
Pharmaceutical, and Trimaran Pharma. The remaining authors declare that
they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Psychiatry, Yale University School of Medicine and VA CT
Healthcare Center, 116A2, 950 Campbell Avenue, West Haven, CT 06516,
USA. 2Department of Psychiatry, Virginia Commonwealth University,
Richmond, VA, USA. 3Department of Psychiatry, University of California San
Diego, La Jolla, CA, USA. 4Department of Family Medicine and Public Health,
Polimanti et al. Genome Medicine  (2017) 9:99 Page 8 of 10
University of California San Diego, La Jolla, CA, USA. 5Veterans Affairs San
Diego Healthcare System and Veterans Affairs Center of Excellence for Stress
and Mental Health, La Jolla, CA, USA. 6Department of Psychiatry and
Behavioral Sciences, Emory University, Atlanta, GA, USA. 7Department of
Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
8Atlanta VA Medical Center, Atlanta, GA, USA. 9Department of Medicine,
Biomedical Genetics Division, Boston University School of Medicine, Boston,
MA, USA. 10Fellow Program and Behavioral Health and Criminal Justice
Division RTI International, Research Triangle Park, NC, USA. 11Department of
Psychiatry, University of Michigan, Ann Arbor, MI, USA. 12Department of
Psychiatry, University of Pennsylvania Perelman School of Medicine and VISN
4 MIRECC, Crescenz VAMC, Philadelphia, PA, USA. 13Department of
Environmental Health, Harvard T. H. Chan School of Public Health, Boston,
MA, USA. 14Department of Genetics, Washington University School of
Medicine, St. Louis, MO, USA. 15Department of Biostatistics, Yale University,
New Haven, CT, USA. 16VA Ann Arbor Health System, Ann Arbor, MI, USA.
17Department of Psychiatry, Harvard University, Cambridge, MA, USA.
18Department of Psychiatry, McLean Hospital, Belmont, MA, USA.
19Department of Epidemiology, Harvard TH Chan School of Public Health,
Boston, MA, USA. 20Psychiatric and Neurodevelopmental Genetics Unit,
Center for Human Genetic Research, and Department of Psychiatry,
Massachusetts General Hospital, Boston, MA, USA. 21Broad Institute of MIT
and Harvard, Stanley Center for Psychiatric Research, Boston, MA, USA.
22Departments of Neuroscience and of Genetics, Yale University School of
Medicine, New Haven, CT, USA.
Received: 28 July 2017 Accepted: 6 November 2017
References
1. Pitman RK, Rasmusson AM, Koenen KC, Shin LM, Orr SP, Gilbertson MW,
et al. Biological studies of post-traumatic stress disorder. Nat Rev Neurosci.
2012;13:769–87.
2. American Psychiatric Association. Trauma- and stressor-related disorders. In:
Diagnostic and Statistical Manual of Mental Disorder. Washington, DC:
American Psychiatric Association; 2013.
3. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress
disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52:
1048–60.
4. Bangasser DA, Valentino RJ. Sex differences in molecular and cellular
substrates of stress. Cell Mol Neurobiol. 2012;32:709–23.
5. Olff M, Langeland W, Draijer N, Gersons BP. Gender differences in
posttraumatic stress disorder. Psychol Bull. 2007;133:183–204.
6. Kilpatrick DG, Resnick HS, Milanak ME, Miller MW, Keyes KM, Friedman MJ.
National estimates of exposure to traumatic events and PTSD prevalence
using DSM-IV and DSM-5 criteria. J Trauma Stress. 2013;26:537–47.
7. Cortina LM, Kubiak SP. Gender and posttraumatic stress: sexual violence
as an explanation for women's increased risk. J Abnorm Psychol. 2006;
115:753–9.
8. Sartor CE, McCutcheon VV, Pommer NE, Nelson EC, Grant JD, Duncan AE,
et al. Common genetic and environmental contributions to post-traumatic
stress disorder and alcohol dependence in young women. Psychol Med.
2011;41:1497–505.
9. True WR, Rice J, Eisen SA, Heath AC, Goldberg J, Lyons MJ, et al. A twin
study of genetic and environmental contributions to liability for
posttraumatic stress symptoms. Arch Gen Psychiatry. 1993;50:257–64.
10. Duncan LE, Ratanatharathorn A, Aiello AE, Almli LM, Amstadter AB, Ashley-
Koch AE, et al. Largest GWAS of PTSD (N=20 070) yields genetic overlap
with schizophrenia and sex differences in heritability. Mol Psychiatry. 2017.
http://doi.org/10.1038/mp.2017.77.
11. Li SH, Graham BM. Why are women so vulnerable to anxiety, trauma-related
and stress-related disorders? The potential role of sex hormones. Lancet
Psychiatry. 2017;4:73–82.
12. Maddox SA, Kilaru V, Shin J, Jovanovic T, Almli LM, Dias BG, et al. Estrogen-
dependent association of HDAC4 with fear in female mice and women
with PTSD. Mol Psychiatry. 2017. http://doi.org/10.1038/mp.2016.250.
13. Pasaniuc B, Price AL. Dissecting the genetics of complex traits using
summary association statistics. Nat Rev Genet. 2017;18:117–27.
14. Polimanti R, Gelernter J, Stein DJ. Genetically determined schizophrenia is
not associated with impaired glucose homeostasis. Schizophr Res. 2017.
http://doi.org/10.1016/j.schres.2017.10.033.
15. Kubzansky LD, Bordelois P, Jun HJ, Roberts AL, Cerda M, Bluestone N, et al. The
weight of traumatic stress: a prospective study of posttraumatic stress disorder
symptoms and weight status in women. JAMA Psychiat. 2014;71:44–51.
16. Yonkers KA, Smith MV, Forray A, Epperson CN, Costello D, Lin H, et al.
Pregnant women with posttraumatic stress disorder and risk of preterm
birth. JAMA Psychiat. 2014;71:897–904.
17. Boyraz G, Granda R, Baker CN, Tidwell LL, Waits JB. Posttraumatic stress,
effort regulation, and academic outcomes among college students: A
longitudinal study. J Couns Psychol. 2016;63:475–86.
18. Bulik-Sullivan B, Finucane HK, Anttila V, Gusev A, Day FR, Loh PR, et al. An
atlas of genetic correlations across human diseases and traits. Nat Genet.
2015;47:1236–41.
19. Bierut LJ, Strickland JR, Thompson JR, Afful SE, Cottler LB. Drug use and
dependence in cocaine dependent subjects, community-based individuals,
and their siblings. Drug Alcohol Depend. 2008;95:14–22.
20. Bierut LJ, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau OF,
et al. Novel genes identified in a high-density genome wide association
study for nicotine dependence. Hum Mol Genet. 2007;16:24–35.
21. Xie P, Kranzler HR, Yang C, Zhao H, Farrer LA, Gelernter J. Genome-wide
association study identifies new susceptibility loci for posttraumatic stress
disorder. Biol Psychiatry. 2013;74:656–63.
22. Almli LM, Stevens JS, Smith AK, Kilaru V, Meng Q, Flory J, et al. A genome-
wide identified risk variant for PTSD is a methylation quantitative trait locus
and confers decreased cortical activation to fearful faces. Am J Med Genet B
Neuropsychiatr Genet. 2015;168B:327–36.
23. Nievergelt CM, Maihofer AX, Mustapic M, Yurgil KA, Schork NJ, Miller MW, et al.
Genomic predictors of combat stress vulnerability and resilience in U.S. Marines:
A genome-wide association study across multiple ancestries implicates PRTFDC1
as a potential PTSD gene. Psychoneuroendocrinology. 2015;51:459–71.
24. Koenen KC, De Vivo I, Rich-Edwards J, Smoller JW, Wright RJ, Purcell SM.
Protocol for investigating genetic determinants of posttraumatic stress
disorder in women from the Nurses’ Health Study II. BMC Psychiatry. 2009;9:29.
25. Liberzon I, King AP, Ressler KJ, Almli LM, Zhang P, Ma ST, et al. Interaction of
the ADRB2 gene polymorphism with childhood trauma in predicting adult
symptoms of posttraumatic stress disorder. JAMA Psychiat. 2014;71:1174–82.
26. Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-
generation PLINK: rising to the challenge of larger and richer datasets.
Gigascience. 2015;4:7.
27. Euesden J, Lewis CM, O’Reilly PF. PRSice: Polygenic Risk Score software.
Bioinformatics. 2015;31:1466–8.
28. International Schizophrenia Consortium, Purcell SM, Wray NR, Stone JL,
Visscher PM, O’Donovan MC, et al. Common polygenic variation contributes
to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748–52.
29. Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic
studies of body mass index yield new insights for obesity biology. Nature.
2015;518:197–206.
30. Winkler TW, Justice AE, Graff M, Barata L, Feitosa MF, Chu S, et al. The influence
of age and sex on genetic associations with adult body size and shape: a
large-scale genome-wide interaction study. PLoS Genet. 2015;11:e1005378.
31. Wood AR, Esko T, Yang J, Vedantam S, Pers TH, Gustafsson S, et al. Defining
the role of common variation in the genomic and biological architecture of
adult human height. Nat Genet. 2014;46:1173–86.
32. Shungin D, Winkler TW, Croteau-Chonka DC, Ferreira T, Locke AE, Magi R,
et al. New genetic loci link adipose and insulin biology to body fat
distribution. Nature. 2015;518:187–96.
33. Perry JR, Day F, Elks CE, Sulem P, Thompson DJ, Ferreira T, et al. Parent-of-
origin-specific allelic associations among 106 genomic loci for age at
menarche. Nature. 2014;514:92–7.
34. Day FR, Ruth KS, Thompson DJ, Lunetta KL, Pervjakova N, Chasman DI, et al.
Large-scale genomic analyses link reproductive aging to hypothalamic
signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nat
Genet. 2015;47:1294–303.
35. Barban N, Jansen R, de Vlaming R, Vaez A, Mandemakers JJ, Tropf FC, et al.
Genome-wide analysis identifies 12 loci influencing human reproductive
behavior. Nat Genet. 2016;48:1462–72.
36. Okbay A, Beauchamp JP, Fontana MA, Lee JJ, Pers TH, Rietveld CA, et al.
Genome-wide association study identifies 74 loci associated with
educational attainment. Nature. 2016;533:539–42.
37. Mi H, Huang X, Muruganujan A, Tang H, Mills C, Kang D, et al. PANTHER version
11: expanded annotation data from Gene Ontology and Reactome pathways,
and data analysis tool enhancements. Nucleic Acids Res. 2017;45:D183–D9.
Polimanti et al. Genome Medicine  (2017) 9:99 Page 9 of 10
38. Supek F, Bosnjak M, Skunca N, Smuc T. REVIGO summarizes and visualizes
long lists of gene ontology terms. PLoS One. 2011;6:e21800.
39. Burgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG, EPIC-InterAct
Consortium. Using published data in Mendelian randomization: a blueprint for
efficient identification of causal risk factors. Eur J Epidemiol. 2015;30:543–52.
40. Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid
instruments: effect estimation and bias detection through Egger regression.
Int J Epidemiol. 2015;44:512–25.
41. Pickrell JK, Berisa T, Liu JZ, Segurel L, Tung JY, Hinds DA. Detection and
interpretation of shared genetic influences on 42 human traits. Nat Genet.
2016;48:709–17.
42. Day FR, Helgason H, Chasman DI, Rose LM, Loh PR, Scott RA, et al. Physical
and neurobehavioral determinants of reproductive onset and success. Nat
Genet. 2016;48:617–23.
43. Burgess S, Davies NM, Thompson SG. Bias due to participant overlap in two-
sample Mendelian randomization. Genet Epidemiol. 2016;40:597–608.
44. Polimanti R, Yang BZ, Zhao H, Gelernter J. Evidence of polygenic
adaptation in the systems genetics of anthropometric traits. PLoS One.
2016;11:e0160654.
45. Fuente-Martin E, Argente-Arizon P, Ros P, Argente J, Chowen JA. Sex
differences in adipose tissue: It is not only a question of quantity and
distribution. Adipocyte. 2013;2:128–34.
46. Gandubert C, Scali J, Ancelin ML, Carriere I, Dupuy AM, Bagnolini G, et al.
Biological and psychological predictors of posttraumatic stress disorder onset
and chronicity. A one-year prospective study. Neurobiol Stress. 2016;3:61–7.
47. Jasienska G, Ziomkiewicz A, Ellison PT, Lipson SF, Thune I. Large breasts and
narrow waists indicate high reproductive potential in women. Proc Biol Sci.
2004;271:1213–7.
48. Strahan EJ, Wilson AE, Cressman KE, Buote VM. Comparing to perfection:
How cultural norms for appearance affect social comparisons and self-
image. Body Image. 2006;3:211–27.
49. Tabet M, Flick LH, Cook CA, Xian H, Chang JJ. Age at first birth and
psychiatric disorders in low-income pregnant women. J Womens Health
(Larchmt). 2016;25:810–7.
50. Hauger RL, Olivares-Reyes JA, Dautzenberg FM, Lohr JB, Braun S, Oakley RH.
Molecular and cell signaling targets for PTSD pathophysiology and
pharmacotherapy. Neuropharmacology. 2012;62:705–14.
51. Singewald N, Schmuckermair C, Whittle N, Holmes A, Ressler KJ.
Pharmacology of cognitive enhancers for exposure-based therapy of fear,
anxiety and trauma-related disorders. Pharmacol Ther. 2015;149:150–90.
52. Noll JG, Shenk CE, Putnam KT. Childhood sexual abuse and adolescent
pregnancy: a meta-analytic update. J Pediatr Psychol. 2009;34:366–78.
53. Boyer D, Fine D. Sexual abuse as a factor in adolescent pregnancy and child
maltreatment. Fam Plann Perspect. 1992;24:4–11. 9.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Polimanti et al. Genome Medicine  (2017) 9:99 Page 10 of 10
